Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MCKESSON CORPORATION

(MCK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about MCKESSON CORPORATION
11/23INSIDER SELL : McKesson
MT
11/14Washington seeks over $38 billion from opioid distributors
AQ
11/12INSIDER SELL : Mckesson
MT
11/08Credit Suisse Adjusts McKesson's Price Target to $230 from $224, Keeps Neutral Rating
MT
11/04INSIDER SELL : Mckesson
MT
11/04McKesson Corporation Opens New Pharmaceutical Distribution Center in Michigan
CI
11/03Ontada Names Sagran Moodley as Chief Innovation and Technology Officer
PU
11/03EXKIVITY (mobocertinib), First and Only FDA Approved Oral Treatment for EGFR Exon20 Ins..
PU
11/03Deutsche Bank Lifts McKesson's Price Target to $279 From $261; Buy Rating Kept
MT
11/03Mizuho Securities Adjusts McKesson's Price Target to $229 From $210, Reiterates Neutral..
MT
11/02Barclays Adjusts McKesson's Price Target to $270 From $255, Reiterates Overweight Ratin..
MT
11/02Tranche Update on McKesson Corporation's Equity Buyback Plan announced on May 24, 2018.
CI
11/01MCKESSON : Fiscal Q2 Earnings Snapshot
AQ
11/01McKesson Fiscal Q2 Gains Beat Street Views; Lifts FY22 EPS Outlook -- Shares Up Nearly ..
MT
11/01McKESSON REPORTS FISCAL 2022 SECOND-QUARTER RESULTS - Form 8-K
PU
More most relevant news
All news about MCKESSON CORPORATION
11/23INSIDER SELL : McKesson
MT
11/15Washington state, in $95 billion opioid trial, blames drug distributors for crisis
RE
11/14Washington seeks over $38 billion from opioid distributors
AQ
11/12INSIDER SELL : Mckesson
MT
11/12Factbox-J&J's legal liabilities as it plans to split
RE
11/09Oklahoma court overturns $465 mln opioid judgment against J&J
RE
11/08Credit Suisse Adjusts McKesson's Price Target to $230 from $224, Keeps Neutral Rating
MT
11/04INSIDER SELL : Mckesson
MT
11/04McKesson Corporation Opens New Pharmaceutical Distribution Center in Michigan
CI
11/03Ontada Names Sagran Moodley as Chief Innovation and Technology Officer
PU
More news
News in other languages on MCKESSON CORPORATION
11/23VENTE PAR DES INITIÉS : McKesson
11/12VENTE D'INITIÉS : Mckesson
11/01Les gains de McKesson au deuxième trimestre dépassent les prévisions de la Bourse ; les..
11/01HISTORIQUE DES RÉACTIONS AUX RÉSULTA : McKesson Corp, indicateur de suivi à 60,0%, sensibl..
11/01MÄRKTE USA/Gewinnmitnahmen nach Dow-Sprung über 36.000-Punktemarke
11/01MÄRKTE USA/Neue Rekordhochs - Harley-Davidson mit Kurssprung
11/01MÄRKTE USA/Börse etwas fester erwartet - Harley-Davidson haussieren
11/01McKesson accepte de vendre ses activités au Royaume-Uni à Aurelius
11/01MARKT USA/Börse etwas fester - Harley-Davidson haussieren
10/28McKesson Corporation déclare un dividende régulier, payable le 3 janvier 2022
More news
Analyst Recommendations on MCKESSON CORPORATION
11/08Credit Suisse Adjusts McKesson's Price Target to $230 from $224, Keeps Neutral Rating
MT
11/03Deutsche Bank Lifts McKesson's Price Target to $279 From $261; Buy Rating Kept
MT
11/03Mizuho Securities Adjusts McKesson's Price Target to $229 From $210, Reiterates Neutral..
MT
11/02Barclays Adjusts McKesson's Price Target to $270 From $255, Reiterates Overweight Ratin..
MT
10/29Morgan Stanley Adjusts Price Target on McKesson to $240 From $226, Maintains Overweight..
MT
More recommendations
Press releases
11/14Washington seeks over $38 billion from opioid distributors
AQ
11/03Ontada Names Sagran Moodley as Chief Innovation and Technology Officer
PU
11/03EXKIVITY (mobocertinib), First and Only FDA Approved Oral Treatment for EGFR Exon20 Ins..
PU
11/02MCKESSON CORP Management's Discussion and Analysis of Financial Condition and Results ..
AQ
11/01MCKESSON : Fiscal Q2 Earnings Snapshot
AQ
More press releases
Upcoming event on MCKESSON CORPORATION